CureVac N.V.
CureVac N.V. (CVAC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CVAC · as of Mar 31, 2025
Ownership Breakdown
85
Institutional Holders
▲ 6 vs Q4
$21.84M
Total Inst. Value
▼ $4.80M vs Q4
225.17M
Shares Outstanding
freeFloat 42.64%
7.87M
13F Shares Held
▲ 12,040 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CVAC largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 1.82M | 80.70% | 80.70% | $5.03B | May 15, 2025 | ▲ 169.9K |
BLACKROCK, INC. pharmaceutical preparations | 1.10M | 48.95% | 48.95% | $3.05B | May 2, 2025 | ▼ 120.8K |
UBS GROUP AG pharmaceutical preparations | 843.2K | 37.45% | 37.45% | $2.34B | May 13, 2025 | ▲ 266.3K |
GSA CAPITAL PARTNERS LLP pharmaceutical preparations | 307.9K | 13.68% | 13.68% | $853.00M | May 8, 2025 | NEW |
UBS ASSET MANAGEMENT AMERICAS INC pharmaceutical preparations | 279.7K | 12.42% | 12.42% | $774.65M | May 19, 2025 | ▲ 3.2K |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 267.4K | 11.88% | 11.88% | $740.71M | Jun 27, 2025 | ▼ 75.9K |
DEUTSCHE BANK AG\ pharmaceutical preparations | 230.8K | 10.25% | 10.25% | $639.35M | May 9, 2025 | ▲ 60.9K |
BNP PARIBAS ARBITRAGE, SNC pharmaceutical preparations | 224.5K | 9.97% | 9.97% | $621.93M | May 14, 2025 | ▲ 52.8K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 218.8K | 9.72% | 9.72% | $606.15M | May 13, 2025 | ▼ 22.9K |
SWISS NATIONAL BANK pharmaceutical preparations | 198.5K | 8.82% | 8.82% | $552.83M | May 12, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
19
Increased
+773.6K shares9
New Positions
first time holders14
Decreased
−389.0K shares0
Sold Out
fully exitedNet shares change (top 50)
+384.7K
+773.6K / −389.0K
Net new holders
+14
9 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CVAC insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CureVac N.V. (CVAC) is primarily owned by institutional investors, who hold approximately 3.5% of total shares outstanding. Company insiders own approximately 57.36%, while retail and public investors account for the remaining 39.14%.
The largest institutional shareholder of CureVac N.V. is MILLENNIUM MANAGEMENT LLC, holding approximately 1.82 million shares — equal to 80.70% of outstanding shares — as of March 31, 2025.
A total of 85 institutional investors currently hold CVAC stock, with a combined institutional value of approximately $21,841,849 as of the most recent 13F filing period.
Frequently asked questions
CVAC ownershipCureVac N.V. (CVAC) is primarily owned by institutional investors, who hold approximately 3.5% of shares. The largest shareholder is MILLENNIUM MANAGEMENT LLC with a 80.70% stake. Company insiders hold 57.36%. Data sourced from SEC Form 13F as of March 31, 2025.